Our team
Multidisciplinary team with deep track record in women’s health & pharma industry

• Graduated as Medical Doctor from UAB and is a Clinical Pharmacologist specialist. GMP at IESE business school
• 14 years of experience in pharmaceutical industry, of which the last 10 years at Bayer, leading Women’s Health and Cardiovascular Therapeutic Area Medical team (8 Medical Affairs & 11 MSL)
• 10 indexed international papers, more than 30 communications in international congresses, more than 20 clinical trials leaded in WH area (TEAM-09, REMO, APPROACH, SEC-QoL), more than 10 products or new indications launched
• Invited professor & mentoring students at Pharmaceutical & Biotech Master, UPF
Agnès Arbat M.D. I CEO I CMO I Founder

• Biochemist, with PhD in Molecular biology from University of Barcelona
• 11 years of experience in pharmaceutical industry as scientific advisor in Women’s Health leading clinical studies and research projects
• Author in 12 indexed publications and 30 official congresses communications in the field of OXO-001 and WH, 4 patents author, responsible for 3 Spanish Ministry of Science research funded projects and 1 doctoral thesis direction
Ignasi Canals PhD I CSO I Founder

• Bachelor’s degree in business administration, Master in Corporate Finance by ESADE and GMP at IESE
• Co-founder of 2 Companies: (i) VTA provides financial services to startups (>100 clients), (ii) C4V is a VC investment club with investment committed over 2M€
• Expert in non-dilutive fundraising for startups, he has developed different financial products for consultancies.
• CFO of 5 BIOTECH companies and member of his BOARDS
Agustí Soler I CFO

• Oncology nurse from Autonomous University of Barcelona
• Proven track record of management national and international clinical trials phase I-IV across a wide variety of therapeutic areas
• Over 20 years working within the CRO field with more than 6 years experience managing international clinical operations teams, and over 5 years experience as Project Manager Director. Experience leading and overseeing studies for global pharma companies, small biotech across Europe and America, as well as experience in setting up FSP service models
• More than 10 years collaborating as teacher in the Pharm Industry Master, CESIF
Marta Llorens I Clinical Operations and compliance lead

• Pharmacist, with Ph.D focused on PCOS drug development from University of Barcelona. Experience in R&D Project management in the pharmaceutical industry for more than 6 years
• PhD in SPIOMET PCOS development plan, awarded by an EU fund of 6.3M€ under project SPIOMET4Health and 3,5M in public funding for several WH projects. Inventor of 2 patents, participated in the launch of RINGO (Nuvaring’s generic). Experience in scientific advisory meetings (EMA and FDA)
• Professor at EADA Business School for International Master in Pharmaceutical and Biotechnology Management
Rosa Torres PhD I Scientific Manager and CMC lead

• Degree in Economics from the University of Barcelona and MBA from Pittsburgh State University
• Broad expertise in BD&L and M&A having led BD & Portoflio at Exeltis Healthcare, led the Rx BD at Galderma, served as International BD for Allergan and led BD&L at SymBio Pharma
• Directly led (or was part of) dozens of transactions of different size and type in Europe, USA, Japan, APAC and Middle East, in different therapeutic areas
Abel Riera I BD advisor